Drug Type Small molecule drug |
Synonyms LP 108, LP-108 |
Target |
Mechanism Bcl-2 inhibitors(Apoptosis regulator Bcl-2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC48H55ClN8O7S |
InChIKeyCCDRQWAEZGRMTP-WJOKGBTCSA-N |
CAS Registry2291166-56-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Lymphocytic Leukemia | Phase 2 | CN | - | |
Small Lymphocytic Lymphoma | Phase 2 | CN | - | |
Myelodysplastic Syndromes | Phase 1 | CN | 07 Feb 2023 | |
Acute Myeloid Leukemia | Phase 1 | US | 06 Jul 2020 | |
Acute Myeloid Leukemia | Phase 1 | US | 06 Jul 2020 | |
Acute Myeloid Leukemia | Phase 1 | CN | 06 Jul 2020 | |
Acute Myeloid Leukemia | Phase 1 | ES | 06 Jul 2020 | |
Acute Myeloid Leukemia | Phase 1 | ES | 06 Jul 2020 | |
Acute Myeloid Leukemia | Phase 1 | GB | 06 Jul 2020 | |
Adult Acute Myeloblastic Leukemia | Phase 1 | US | 06 Jul 2020 |
NCT04356846 (EHA2024) Manual | Phase 1 | 33 | yaawzjicst(esfrhewegt) = fcimjtqtlf zpcoshkpjv (fywnicdxgb ) View more | Positive | 14 May 2024 | ||
Phase 1 | 49 | gnrclbmwae(gvxnqpoprf) = wcbufvghpe pcloewzgwu (quspffxidz ) View more | - | 08 Jun 2023 | |||
Phase 1 | 32 | erhiyhpgqc(cgjletwggg) = qjonqdozqz ptpcmaurmd (iaxkqkuhgt ) View more | - | 08 Jun 2023 | |||
erhiyhpgqc(cgjletwggg) = vihahwffww ptpcmaurmd (iaxkqkuhgt ) View more | |||||||
NCT04356846 (EHA2022) Manual | Phase 1 | 19 | canzfdpoud(pnuapgbker) = blzqbefvts djiovnrrbq (jpmaqonwof ) View more | Positive | 12 May 2022 |